Kazia Therapeutics has two novel classes of anticancer drugs Edison Investment Research

Kazia Therapeutics has two novel classes of anti-cancer drugs: Edison Investment Research

18:34 EDT 27 Jun 2019 | Proactive Investors

A new collaboration with the Alliance for clinical trials in oncology means Kazia will soon have four clinical trials of GDC-0084 underway in primary or secondary brain cancers.

More From BioPortfolio on "Kazia Therapeutics has two novel classes of anti-cancer drugs: Edison Investment Research"